641 related articles for article (PubMed ID: 17353514)
1. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
[TBL] [Abstract][Full Text] [Related]
2. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Circ Res; 2001 Nov; 89(11):969-76. PubMed ID: 11717152
[TBL] [Abstract][Full Text] [Related]
3. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors.
Just A; Olson AJ; Arendshorst WJ
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F660-8. PubMed ID: 14678950
[TBL] [Abstract][Full Text] [Related]
4. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
[TBL] [Abstract][Full Text] [Related]
5. Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes.
Bender SB; Klabunde RE
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2281-8. PubMed ID: 17660396
[TBL] [Abstract][Full Text] [Related]
6. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease.
Böhm F; Jensen J; Svane B; Settergren M; Pernow J
Can J Physiol Pharmacol; 2008 Nov; 86(11):745-51. PubMed ID: 19011669
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis.
Larose E; Behrendt D; Kinlay S; Selwyn AP; Ganz P; Fang JC
Circ Heart Fail; 2009 Sep; 2(5):409-16. PubMed ID: 19808370
[TBL] [Abstract][Full Text] [Related]
9. Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.
Wenner MM; Taylor HS; Stachenfeld NS
J Physiol; 2011 Oct; 589(Pt 19):4671-9. PubMed ID: 21825025
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor blockade improves endothelial function in human internal mammary arteries.
Verma S; Lovren F; Dumont AS; Mather KJ; Maitland A; Kieser TM; Kidd W; McNeill JH; Stewart DJ; Triggle CR; Anderson TJ
Cardiovasc Res; 2001 Jan; 49(1):146-51. PubMed ID: 11121806
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphoramidon, BQ 788, and BQ 123 on coronary and cardiac dysfunctions of the failing hamster heart.
Fontaine ER; Viau S; Jasmin G; Dumont L
J Cardiovasc Pharmacol; 1998 Jul; 32(1):12-20. PubMed ID: 9676715
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.
Verhaar MC; Strachan FE; Newby DE; Cruden NL; Koomans HA; Rabelink TJ; Webb DJ
Circulation; 1998 Mar; 97(8):752-6. PubMed ID: 9498538
[TBL] [Abstract][Full Text] [Related]
13. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia.
Allahdadi KJ; Cherng TW; Pai H; Silva AQ; Walker BR; Nelin LD; Kanagy NL
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H434-40. PubMed ID: 18515645
[TBL] [Abstract][Full Text] [Related]
14. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
Matsumoto T; Ozawa Y; Taguchi K; Kobayashi T; Kamata K
Peptides; 2010 Feb; 31(2):346-53. PubMed ID: 19962413
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits.
Dumont AS; Lovren F; McNeill JH; Sutherland GR; Triggle CR; Anderson TJ; Verma S
J Neurosurg; 2001 Feb; 94(2):281-6. PubMed ID: 11213966
[TBL] [Abstract][Full Text] [Related]
16. ET-1-induced pulmonary vasoconstriction shifts from ET(A)- to ET(B)-receptor-mediated reaction after preconstriction.
Schmeck J; Gluth H; Mihaljevic N; Born M; Wendel-Wellner M; Krafft P
J Appl Physiol (1985); 1999 Dec; 87(6):2284-9. PubMed ID: 10601179
[TBL] [Abstract][Full Text] [Related]
17. Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung.
Janosi T; Peták F; Fontao F; Morel DR; Beghetti M; Habre W
Exp Physiol; 2008 Nov; 93(11):1210-9. PubMed ID: 18567602
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 increases superoxide production in human coronary artery bypass grafts.
Cerrato R; Cunnington C; Crabtree MJ; Antoniades C; Pernow J; Channon KM; Böhm F
Life Sci; 2012 Oct; 91(13-14):723-8. PubMed ID: 22483692
[TBL] [Abstract][Full Text] [Related]
19. Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia.
Guo QH; Tian YL; Wang Z; Li AY; Ma ZH; Guo YJ; Weiss JW; Ji ES; Chu L
Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):449-57. PubMed ID: 23662699
[TBL] [Abstract][Full Text] [Related]
20. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
Mickley EJ; Gray GA; Webb DJ
Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
